Univest
Univest
  • Markets
  • Aarey Drugs Analyst Review 2027: A Stock That Doubled on a Business Earning ₹1.37 Crore a Quarter

    • November 17, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    Aarey Drugs Analyst Review 2027: A Stock That Doubled on a Business Earning ₹1.37 Crore a Quarter

    Aarey Drugs & Pharmaceuticals has more than doubled from its 52-week low, yet it earned just ₹1.37 crore in Q2 FY27 and has no brokerage coverage. We look at the numbers behind the rally, margins, valuation and risks for 2027.

    read more